obstructive sleep apneu syndrome (OSAS)
Conditions
Interventions
Two weeks of nocturnal use of continuous positive airway pressure (CPAP), sham
CPAP or no treatment followed by two weeks of nocturnal CPAP or no treatment.
Sponsors
Heliomare
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: First-time stroke confirmed by neurological assessment and CT or MRI scan Baseline measurement (T
Exclusion criteria
Exclusion criteria: Severe unstable medical conditions Severe cardiac problems (like angina pectoris or pacemaker/ventricular impairments) Severe pulmonal disease (severe dyspnea of effort or severe pulmonal emphysema) Severe aphasia or confusion, which could strongly influence the performance on the neuropsychological assessment Severe psychiatric or somatic comorbidity, which could strongly influence the performance on the neuropsychological assessment Central SAS only
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes of this study are fatigue, cognitive and emotional functioning, and daily living activities (neuropsychological evaluation). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary measures are sleep quality and cerebral functioning. Sociodemographic and clinical data, CPAP compliance and nocturnal arousal will also be included as control measures. | — |
Countries
Netherlands
Outcome results
None listed